Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph I Kang

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Chemical Research in Toxicology|May 3, 2008
Hypochlorous acid damages histone proteins forming 3-chlorotyrosine and 3,5-dichlorotyrosineJoseph I Kang, Jonathan W Neidigh
Chemical Research in Toxicology|October 2, 2008
Examination of hypochlorous acid-induced damage to cytosine residues in a CpG dinucleotide in DNAJoseph I Kang, Lawrence C Sowers
Chemical Research in Toxicology|September 21, 2004
Synthesis and characterization of oligonucleotides containing 5-chlorocytosineJoseph I Kang, Artur Burdzy, Pingfang Liu, et al.
Nucleic Acids Research|May 27, 2005
5-halogenated pyrimidine lesions within a CpG sequence context mimic 5-methylcytosine by enhancing the binding of the methyl-CpG-binding domain of methyl-CpG-binding protein 2 (MeCP2)Victoria Valinluck, Pingfang Liu, Joseph I Kang, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|January 30, 2013
Proton therapy for hepatocellular carcinomaTed C Ling, Joseph I Kang, David A Bush, et al.
Surgical Neurology International|March 12, 2024
Adjuvant proton beam therapy in patients with grade 2 meningiomasTaylor Anne Wilson, Joseph I Kang, Lei Huang, et al.
Journal of Gastrointestinal Oncology|February 22, 2019
A phase I trial of Proton stereotactic body radiation therapy for liver metastasesJoseph I Kang, Daniel C Sufficool, Chung-Tsen Hsueh, et al.
International Journal of Particle Therapy|November 28, 2019
Hypofractionated Proton Therapy in Early Prostate Cancer: Results of a Phase I/II Trial at Loma Linda UniversityJason M Slater, Jerry D Slater, Joseph I Kang, et al.
Journal of Gastrointestinal Oncology|September 17, 2021
Proton stereotactic body radiation therapy for liver metastases-results of 5-year experience for 81 hepatic lesionsAlex R Coffman, Daniel C Sufficool, Joseph I Kang, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Chemical Research in Toxicology|May 3, 2008
Hypochlorous acid damages histone proteins forming 3-chlorotyrosine and 3,5-dichlorotyrosineJoseph I Kang, Jonathan W Neidigh
Chemical Research in Toxicology|October 2, 2008
Examination of hypochlorous acid-induced damage to cytosine residues in a CpG dinucleotide in DNAJoseph I Kang, Lawrence C Sowers
Chemical Research in Toxicology|September 21, 2004
Synthesis and characterization of oligonucleotides containing 5-chlorocytosineJoseph I Kang, Artur Burdzy, Pingfang Liu, et al.
Nucleic Acids Research|May 27, 2005
5-halogenated pyrimidine lesions within a CpG sequence context mimic 5-methylcytosine by enhancing the binding of the methyl-CpG-binding domain of methyl-CpG-binding protein 2 (MeCP2)Victoria Valinluck, Pingfang Liu, Joseph I Kang, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|January 30, 2013
Proton therapy for hepatocellular carcinomaTed C Ling, Joseph I Kang, David A Bush, et al.
Surgical Neurology International|March 12, 2024
Adjuvant proton beam therapy in patients with grade 2 meningiomasTaylor Anne Wilson, Joseph I Kang, Lei Huang, et al.
Journal of Gastrointestinal Oncology|February 22, 2019
A phase I trial of Proton stereotactic body radiation therapy for liver metastasesJoseph I Kang, Daniel C Sufficool, Chung-Tsen Hsueh, et al.
International Journal of Particle Therapy|November 28, 2019
Hypofractionated Proton Therapy in Early Prostate Cancer: Results of a Phase I/II Trial at Loma Linda UniversityJason M Slater, Jerry D Slater, Joseph I Kang, et al.
Journal of Gastrointestinal Oncology|September 17, 2021
Proton stereotactic body radiation therapy for liver metastases-results of 5-year experience for 81 hepatic lesionsAlex R Coffman, Daniel C Sufficool, Joseph I Kang, et al.
Pageof 1